Page last updated: 2024-08-16

n-methylquipazine and 6-nitroquipazine

n-methylquipazine has been researched along with 6-nitroquipazine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S	1
Anzini, M; Bruni, G; Canullo, L; Cappelli, A; De Benedetti, PG; Donati, A; Doucet, E; Giorgi, G; Hamon, M; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S	1

Other Studies

2 other study(ies) available for n-methylquipazine and 6-nitroquipazine

Article	Year
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives. Journal of medicinal chemistry, 1998, Feb-26, Volume: 41, Issue:5 Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured	1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors. Journal of medicinal chemistry, 1999, May-06, Volume: 42, Issue:9 Topics: Animals; Binding, Competitive; Brain; Cell Line; Granisetron; In Vitro Techniques; Ligands; Male; Mice; Models, Molecular; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship	1999

Article

Year

Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.

Journal of medicinal chemistry, 1998, Feb-26, Volume: 41, Issue:5

Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured

1998

Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.

Journal of medicinal chemistry, 1999, May-06, Volume: 42, Issue:9

Topics: Animals; Binding, Competitive; Brain; Cell Line; Granisetron; In Vitro Techniques; Ligands; Male; Mice; Models, Molecular; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship

1999